We are live on ! Find out more
Vident Advisory

Vident Advisory Portfolio holdings

AUM $13.9B Turnover 17.94%
1-Year Est. Return 53.47%
 

Vident Asset Management writes the indexes behind its own ETFs and also manages ETFs and mutual funds for other firms. For individuals, high net worth individuals, charities and companies, it runs custom accounts, including laddered bond portfolios in municipal, corporate and other bond strategies. Equity accounts can apply environmental, governance or social screens chosen by the account owner. Vident is owned by Vident Capital Holdings, which is controlled by a company owned by Casey Crawford.

This Fund
S&P 500
This Quarter Est. Return
+33.82%
1 Year Est. Return
+53.47%
3 Year Est. Return
+164.32%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$13.9B
AUM Growth
+$2.11B
Cap. Flow
-$471M
Cap. Flow %
-3.4%
Top 10 Hldgs %
20.48%
Holding
2,062
New
227
Increased
871
Reduced
739
Closed
143
Avg Time Held Equity + Options
1.6 years
Top 10 Avg Time Held Equity + Options
1.3 years
Top 20 Avg Time Held Equity + Options
1.5 years
Avg Time Held Equity only
1.6 years
Top 10 Avg Time Held Equity only
1.3 years
Top 20 Avg Time Held Equity only
1.5 years

Top Buys

Rank Stock Value
1
SNDK icon
Sandisk
SNDK
+$31.6M
2
SPOT icon
Spotify
SPOT
+$27.5M
3
PLTR icon
Palantir
PLTR
+$26.2M
4
WSO icon
Watsco Inc
WSO
+$19.5M
5
COF icon
Capital One
COF
+$19.4M

Sector Composition

Rank Sector Weight
1 Technology 37.6%
2 Industrials 13.57%
3 Financials 10.73%
4 Miscellaneous 8.13%
5 Consumer Discretionary 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GDRX icon
1251
GoodRx Holdings
GDRX
$1.2B
$618K ﹤0.01%
+214,489
New +$545K
2026 Q2
0 quarters
DKS icon
1252
Dick's Sporting Goods
DKS
$13.9B
$618K ﹤0.01%
2,723
+96
+4% +$21.2K
2023 Q3
11 quarters
SMTC icon
1253
Semtech
SMTC
$9.6B
$617K ﹤0.01%
3,810
-476
-11% -$62.2K
2025 Q1
5 quarters
MMSI icon
1254
Merit Medical Systems
MMSI
$5.23B
$616K ﹤0.01%
8,887
+423
+5% +$27.9K
2026 Q1
1 quarter
SYM icon
1255
Symbotic
SYM
$4.78B
$615K ﹤0.01%
13,673
+3,695
+37% +$188K
2025 Q2
4 quarters
LB icon
1256
LandBridge Corporation
LB
$1.93B
$611K ﹤0.01%
7,710
-595
-7% -$40.9K
2025 Q4
2 quarters
MOH icon
1257
Molina Healthcare
MOH
$10.9B
$610K ﹤0.01%
2,669
-67
-2% -$12.1K
2023 Q4
10 quarters
MIRM icon
1258
Mirum Pharmaceuticals
MIRM
$6.12B
$609K ﹤0.01%
5,198
+565
+12% +$56.7K
2026 Q1
1 quarter
VMI icon
1259
Valmont Industries
VMI
$7.74B
$608K ﹤0.01%
1,053
-511
-33% -$257K
2025 Q1
5 quarters
OHI icon
1260
Omega Healthcare
OHI
$14.7B
$608K ﹤0.01%
12,755
-240
-2% -$11.1K
2023 Q3
11 quarters
HSAI icon
1261
Hesai Group
HSAI
$2.26B
$608K ﹤0.01%
33,368
+14,166
+74% +$290K
2025 Q2
4 quarters
NPKI icon
1262
NPK International
NPKI
$725M
$605K ﹤0.01%
38,003
+414
+1% +$6.25K
2026 Q1
1 quarter
CPK icon
1263
Chesapeake Utilities
CPK
$3.54B
$604K ﹤0.01%
4,934
-150
-3% -$18.8K
2026 Q1
1 quarter
RL icon
1264
Ralph Lauren
RL
$22.3B
$603K ﹤0.01%
1,502
+167
+13% +$62.2K
2025 Q1
5 quarters
PENG icon
1265
Penguin Solutions Inc
PENG
$2.14B
$603K ﹤0.01%
7,929
-7,824
-50% -$356K
2026 Q1
1 quarter
LPG icon
1266
Dorian LPG
LPG
$2B
$600K ﹤0.01%
17,263
-1,617
-9% -$63.7K
2024 Q3
7 quarters
ORI icon
1267
Old Republic International
ORI
$9.5B
$598K ﹤0.01%
14,621
+93
+0.6% +$3.69K
2023 Q4
10 quarters
RUN icon
1268
Sunrun
RUN
$2.41B
$598K ﹤0.01%
44,675
+5,596
+14% +$75.5K
2025 Q2
4 quarters
FIZZ icon
1269
National Beverage
FIZZ
$3.48B
$598K ﹤0.01%
+19,155
New +$668K
2026 Q2
0 quarters
AMBA icon
1270
Ambarella
AMBA
$2.58B
$597K ﹤0.01%
6,954
+757
+12% +$52.1K
2025 Q2
4 quarters
HLIO icon
1271
Helios Technologies
HLIO
$1.56B
$597K ﹤0.01%
+6,684
New +$513K
2026 Q2
0 quarters
RNW icon
1272
ReNew
RNW
$2.53B
$596K ﹤0.01%
95,377
+21,285
+29% +$120K
2026 Q1
1 quarter
TGTX icon
1273
TG Therapeutics
TGTX
$9.16B
$594K ﹤0.01%
10,811
-408
-4% -$16.7K
2024 Q3
7 quarters
VALE icon
1274
Vale
VALE
$49.3B
$594K ﹤0.01%
39,484
-331,287
-89% -$5.4M
2023 Q3
11 quarters
SLAB icon
1275
Silicon Laboratories
SLAB
$7.39B
$593K ﹤0.01%
2,714
+616
+29% +$133K
2025 Q2
4 quarters

Similar funds

Vident Advisory's Q2 2026 Portfolio in Review

As of Q2 2026, Vident Advisory held 2,062 positions worth $13.9B, up 18% from $11.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Vident Advisory withdrew a net $471M in Q2 2026, closing 143 positions and reducing 739 holdings. Its most notable exit was iShares MSCI Emerging Markets ex China ETF, an estimated $58.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Industrials and Financials.

Against the trend, Vident Advisory opened a new position in Honeywell Aerospace worth $8.59M.

  • Vident Advisory's largest Q2 2026 buy was Honeywell Aerospace: 38,838 shares worth $8.59M.
  • Vident Advisory added most to Sandisk in Q2 2026, an estimated $31.6M increase.
  • Vident Advisory's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $243M.
  • Vident Advisory fully exited iShares MSCI Emerging Markets ex China ETF in Q2 2026, selling an estimated $58.8M.
  • Vident Advisory's ten largest holdings make up 20% of its $13.9B portfolio in Q2 2026.
  • Vident Advisory opened 227 new positions and closed 143 in Q2 2026.
  • Vident Advisory's portfolio value rose 18% quarter-over-quarter to $13.9B.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.